What Constitutes an “Adequate” Trial in Migraine Prevention?

Jonathan H. Smith, Todd J Schwedt

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Comprehensively assessing the quality of prior preventive treatment attempts often reveals modifiable variables that may account for treatment failure. Similarly, a comprehensive and systematic approach when planning a preventive medication trial is critical for optimizing the chances of treatment success. In this review, we summarize the key elements to be included when assessing the adequacy of a preventive treatment trial. We have developed and included checklists that can be used by providers to improve their assessments of prior preventive treatment trials and to assist with planning a high-quality treatment trial with a new migraine preventive medication.

Original languageEnglish (US)
Article number52
JournalCurrent Pain and Headache Reports
Volume19
Issue number11
DOIs
StatePublished - Nov 22 2015

Fingerprint

Treatment Failure
Checklist
Migraine Disorders

Keywords

  • Clinical trial
  • Migraine
  • Outcome
  • Prevention
  • Quality

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

What Constitutes an “Adequate” Trial in Migraine Prevention? / Smith, Jonathan H.; Schwedt, Todd J.

In: Current Pain and Headache Reports, Vol. 19, No. 11, 52, 22.11.2015.

Research output: Contribution to journalArticle

@article{da2aca78f19d4c9fb1f36828f1b4120f,
title = "What Constitutes an “Adequate” Trial in Migraine Prevention?",
abstract = "Comprehensively assessing the quality of prior preventive treatment attempts often reveals modifiable variables that may account for treatment failure. Similarly, a comprehensive and systematic approach when planning a preventive medication trial is critical for optimizing the chances of treatment success. In this review, we summarize the key elements to be included when assessing the adequacy of a preventive treatment trial. We have developed and included checklists that can be used by providers to improve their assessments of prior preventive treatment trials and to assist with planning a high-quality treatment trial with a new migraine preventive medication.",
keywords = "Clinical trial, Migraine, Outcome, Prevention, Quality",
author = "Smith, {Jonathan H.} and Schwedt, {Todd J}",
year = "2015",
month = "11",
day = "22",
doi = "10.1007/s11916-015-0525-9",
language = "English (US)",
volume = "19",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Current Science, Inc.",
number = "11",

}

TY - JOUR

T1 - What Constitutes an “Adequate” Trial in Migraine Prevention?

AU - Smith, Jonathan H.

AU - Schwedt, Todd J

PY - 2015/11/22

Y1 - 2015/11/22

N2 - Comprehensively assessing the quality of prior preventive treatment attempts often reveals modifiable variables that may account for treatment failure. Similarly, a comprehensive and systematic approach when planning a preventive medication trial is critical for optimizing the chances of treatment success. In this review, we summarize the key elements to be included when assessing the adequacy of a preventive treatment trial. We have developed and included checklists that can be used by providers to improve their assessments of prior preventive treatment trials and to assist with planning a high-quality treatment trial with a new migraine preventive medication.

AB - Comprehensively assessing the quality of prior preventive treatment attempts often reveals modifiable variables that may account for treatment failure. Similarly, a comprehensive and systematic approach when planning a preventive medication trial is critical for optimizing the chances of treatment success. In this review, we summarize the key elements to be included when assessing the adequacy of a preventive treatment trial. We have developed and included checklists that can be used by providers to improve their assessments of prior preventive treatment trials and to assist with planning a high-quality treatment trial with a new migraine preventive medication.

KW - Clinical trial

KW - Migraine

KW - Outcome

KW - Prevention

KW - Quality

UR - http://www.scopus.com/inward/record.url?scp=84941930730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941930730&partnerID=8YFLogxK

U2 - 10.1007/s11916-015-0525-9

DO - 10.1007/s11916-015-0525-9

M3 - Article

C2 - 26362764

AN - SCOPUS:84941930730

VL - 19

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 11

M1 - 52

ER -